We just don’t know what the patient is getting when they get it from a compounder,” she said. “We don’t know how effective it’s going to be. It may have other ...
Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these ...
The FDA is reportedly considering broadening the types of drugs that can be sold without a prescription, a move some pharmacy experts say could raise safety risks ...
President Donald Trump has said that Americans are now paying or will pay "the lowest price anywhere in the world for drugs," thanks to the administration’s negotiations with pharmaceutical companies.
The use of biosimilars saved Blue Cross members and employee groups $67 million in 2024 and $80 million in 2025, according to a news release. The savings come amid a cost-cutting push at Blue Cross to ...
The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...
An analysis finds that pharmas frequently file multiple similar patents on drugs, then use them as the basis for questionable litigation against would-be competitors.
Chinese pharmaceutical companies that as a group chalked up record outbound licensing agreements with international industry ...
Observers are calling proposed changes to state-funded HIV assistance its biggest rollback since the aid went into place.
Indian drugmaker Dr Reddy’s Laboratories hopes to launch a generic version of Novo Nordisk’s blockbuster weight‑loss drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results